Danaher Corporation
DHRNYSEHealthcare● Active
$183.53
$-0.77(-0.42%)
Market Cap$129.9B
P/E Ratio—
52W High$242.8
52W Low$160.93
Danaher Corporation (DHR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DHR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 21, 2026EPS Actual
$2.06
Est. $1.94 · +6.2%
Revenue
$5.95B
Est. $5.98B · -0.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 21, 2026
After Market Close
▲ Beat EPS🔥 11-Quarter EPS Beat Streak
DHR reports quarterly as a NYSE-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $1.85 | — | — | — | $6.09B | — |
| ▲ Q2 FY2026 | Apr 21, 2026 | $1.94 | $2.06 | +6.2% | $5.95B | $5.98B | -0.5% |
| ▲ Q1 FY2026 | Jan 28, 2026 | $2.16 | $2.23 | +3.2% | $6.84B | $6.81B | +0.4% |
| ▲ Q4 FY2025 | Oct 21, 2025 | $1.72 | $1.89 | +9.9% | $6.05B | $6.00B | +0.9% |
| ▲ Q3 FY2025 | Jul 22, 2025 | $1.64 | $1.80 | +9.8% | $5.94B | $5.84B | +1.7% |
| ▲ Q2 FY2025 | Apr 22, 2025 | $1.63 | $1.88 | +15.3% | $5.74B | $5.57B | +3.0% |
| — Q1 FY2025 | Jan 29, 2025 | $2.14 | $2.14 | +0.0% | $6.54B | $6.45B | +1.4% |
| ▲ Q4 FY2024 | Oct 22, 2024 | $1.57 | $1.71 | +8.9% | $5.80B | $5.59B | +3.8% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$1.85
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 21, 2026Beat
EPS Actual
$2.06
EPS Est.
$1.94
EPS Surpr.
+6.2%
Revenue
$5.95B
Q1 FY2026
Jan 28, 2026Beat
EPS Actual
$2.23
EPS Est.
$2.16
EPS Surpr.
+3.2%
Revenue
$6.84B
Q4 FY2025
Oct 21, 2025Beat
EPS Actual
$1.89
EPS Est.
$1.72
EPS Surpr.
+9.9%
Revenue
$6.05B
Q3 FY2025
Jul 22, 2025Beat
EPS Actual
$1.80
EPS Est.
$1.64
EPS Surpr.
+9.8%
Revenue
$5.94B
Q2 FY2025
Apr 22, 2025Beat
EPS Actual
$1.88
EPS Est.
$1.63
EPS Surpr.
+15.3%
Revenue
$5.74B
Q1 FY2025
Jan 29, 2025
EPS Actual
$2.14
EPS Est.
$2.14
EPS Surpr.
+0.0%
Revenue
$6.54B
Q4 FY2024
Oct 22, 2024Beat
EPS Actual
$1.71
EPS Est.
$1.57
EPS Surpr.
+8.9%
Revenue
$5.80B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $2.79 | $2.82 | $2.91 | 7 |
| Q3 FY2028 | $2.24 | $2.26 | $2.34 | 9 |
| Q2 FY2028 | $2.08 | $2.10 | $2.17 | 7 |
| Q1 FY2028 | $2.23 | $2.26 | $2.34 | 11 |
| Q4 FY2027 | $2.65 | $2.68 | $2.77 | 10 |
| Q3 FY2027 | $2.16 | $2.19 | $2.26 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $7.8B | $7.8B | $8.0B | 5 |
| Q3 FY2028 | $6.8B | $6.8B | $7.0B | 5 |
| Q2 FY2028 | $6.6B | $6.7B | $6.9B | 5 |
| Q1 FY2028 | $6.5B | $6.5B | $6.7B | 5 |
| Q4 FY2027 | $7.5B | $7.6B | $7.8B | 11 |
| Q3 FY2027 | $6.6B | $6.7B | $6.8B | 11 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 21, 2026 | +6.2% | $195.50 | $194.54 | -0.49% |
| ▲ Q1 FY2026 | Jan 28, 2026 | +3.2% | $235.75 | $224.54 | -4.76% |
| ▲ Q4 FY2025 | Oct 21, 2025 | +9.9% | $208.39 | $220.77 | +5.94% |
| ▲ Q3 FY2025 | Jul 22, 2025 | +9.8% | $188.07 | $189.91 | +0.98% |
| ▲ Q2 FY2025 | Apr 22, 2025 | +15.3% | $184.96 | $192.07 | +3.84% |
| ▲ Q1 FY2025 | Jan 29, 2025 | +0.0% | $247.84 | $223.73 | -9.73% |
| ▲ Q4 FY2024 | Oct 22, 2024 | +8.9% | $272.09 | $261.28 | -3.97% |
| ▲ Q3 FY2024 | Jul 23, 2024 | +9.6% | $250.89 | $264.18 | +5.30% |
Q2 FY2026-0.49%
Report Date
Apr 21, 2026
EPS Beat/Miss
+6.2%
Price Before
$195.50
Price After
$194.54
Q1 FY2026-4.76%
Report Date
Jan 28, 2026
EPS Beat/Miss
+3.2%
Price Before
$235.75
Price After
$224.54
Q4 FY2025+5.94%
Report Date
Oct 21, 2025
EPS Beat/Miss
+9.9%
Price Before
$208.39
Price After
$220.77
Q3 FY2025+0.98%
Report Date
Jul 22, 2025
EPS Beat/Miss
+9.8%
Price Before
$188.07
Price After
$189.91
Q2 FY2025+3.84%
Report Date
Apr 22, 2025
EPS Beat/Miss
+15.3%
Price Before
$184.96
Price After
$192.07
Q1 FY2025-9.73%
Report Date
Jan 29, 2025
EPS Beat/Miss
+0.0%
Price Before
$247.84
Price After
$223.73
Q4 FY2024-3.97%
Report Date
Oct 22, 2024
EPS Beat/Miss
+8.9%
Price Before
$272.09
Price After
$261.28
Q3 FY2024+5.30%
Report Date
Jul 23, 2024
EPS Beat/Miss
+9.6%
Price Before
$250.89
Price After
$264.18
Avg Beat Reaction-0.36%
Beat Rate8 / 8 quarters
Largest Move-9.73% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DHR ends December
Danaher Corporation (DHR) most recently reported earnings on April 21, 2026 for Q2 FY2026, posting EPS of $2.06 — beating the analyst consensus of $1.94 by +6.2%. DHR has beaten EPS estimates for 11 consecutive quarters. The next DHR earnings date is expected around September 1, 2026.
Each quarter, investors track DHR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DHR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DHR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DHR earnings · 5 questionsDanaher Corporation's next earnings report is expected around September 1, 2026. DHR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DHR historically reports after market close (AMC).
DHR earnings datewhen is DHR earningsDHR next earnings datewhen does DHR report earningsDHR earnings calendar
▸ Source: FMP · Danaher Corporation SEC filings · US GAAP · Danaher Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026